& Jones, K.A
Markers of Oxidative Stress in Patients with Psoriasis A total of 53 studies evaluated the following markers or parameters of oxidative stress in patients with psoriasis and also the correlations between those markers and severity and duration of disease: catalase (CAT), myeloperoxidase (MPO), ferroxidase (FOX), ischemia modified albumin (IMA), paraoxonase-1 (PON-1), total oxidant status (TOS), total antioxidant status (TAS), malondialdehyde (MDA), 8-hydroxy 2-deoxyguanosine (8H2D), advanced oxidation protein products (AOPP), nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase), reactive oxygen species (ROS), glutathione peroxidase (GSH-Px), glutathione (GSH), thioredoxin reductase (TrxR), ferric reducing ability of plasma (FRAP), arylesterase (AS), oxidative stress index (OSI), salivary peroxidase (Px), superoxide dismutase (SOD), advanced glycation end-products (AGE), lipid hydroperoxides (LOOH), oxidized LDL (OxLDL), nitric oxide (NO), 8-hydroxy guanosine (8-OHdG), inducible nitric oxide synthase (iNOS), glutathione reductase (GSH-R), 25-hydroxy vitamin D (25-OH-vitD), adenosine deaminase (ADA), thiobarbituric acid (TBA), total peroxide concentration (TPX), protein carbonyl compounds (PCC), pyrrolized protein (PP), oxidized glutathione (GSSG), total bilirubin (TB), direct bilirubin (DB), indirect bilirubin (IB), copper (Cu), iron (Fe), transferrin (Trf), autoantibodies anti-oxidized LDL (AuAb-oxLDL), interleukin-6 (IL-6), C-reactive protein (CRP), antibodies against carboxyethyllysine (Ab anti-CEL) and antibodies against carbocymethyllysine (Ab anti CML) [14,15,16,17,18,19,20,21,22,23,24,25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57,58,59,60,61,62,63,64,65,66]
Crosstalk Between MicroRNA and Oxidative Stress in Primary Open-Angle Glaucoma
This panel of experts drawn from across sectors have a vast pool of expertise working in complex international and domestic political environments
In total, nine treated patients had significantly reduced discomfort and improved tear volume production, even 28 days following treatment
